M. Xia

ORCID: 0000-0003-2559-6288
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Angiogenesis and VEGF in Cancer
  • Health and Medical Research Impacts
  • Lung Cancer Treatments and Mutations
  • Gastric Cancer Management and Outcomes
  • Colorectal Cancer Treatments and Studies
  • Diversity and Career in Medicine
  • Colorectal Cancer Screening and Detection
  • Pharmaceutical industry and healthcare
  • Cancer Treatment and Pharmacology

Zigong First People's Hospital
2024

University of British Columbia
2024

To investigate sex, racial, and ethnic disparities in patient enrollment across cataract trials registered the United States.

10.1097/j.jcrs.0000000000001395 article EN Journal of Cataract & Refractive Surgery 2024-01-18

Vascular endothelial growth factor receptor 2 (VEGFR2) plays a key role in antiangiogenesis which has been an essential strategy for cancer treatment. We report the first-in-human study of AK109, novel anti-VEGFR2 monoclonal antibody, to characterize safety profile and pharmacokinetics/pharmacodynamics (PK/PD) properties, explore preliminary antitumor efficacy patients with solid tumors.This was multicenter, open-label, phase I study, including dose escalation expansion (NCT04547205)....

10.1016/j.esmoop.2023.101156 article EN cc-by-nc-nd ESMO Open 2023-03-28

High-quality bowel preparation is paramount for a successful colonoscopy. This study aimed to explore the effect of artificial intelligence-driven smartphone software on quality preparation.

10.1080/00365521.2024.2443520 article EN Scandinavian Journal of Gastroenterology 2024-12-22
Coming Soon ...